WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2013126707) MEDICAL TRAINING KITS AND METHODS TO SIMULATE TREATMENT OF UNCONTROLLED HEMORRHAGE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2013/126707    International Application No.:    PCT/US2013/027329
Publication Date: 29.08.2013 International Filing Date: 22.02.2013
IPC:
A61K 35/14 (2006.01), A61K 35/12 (2006.01), A61K 33/06 (2006.01), A61K 33/14 (2006.01), A61P 17/02 (2006.01)
Applicants: LUNA INNOVATIONS INCORPORATED [US/US]; 1 Riverside Circle, Suite 400 Roanoke, VA 24016 (US)
Inventors: DAY, Bradford, L.; (US).
DANILICH, Michael, J.; (US)
Agent: DAVIDSON, Bryan, H.; Nixon & Vanderhye P.C. 901 North Glebe Road, 11th Floor Arlington, VA 22203-1808 (US)
Priority Data:
13/405,200 24.02.2012 US
Title (EN) MEDICAL TRAINING KITS AND METHODS TO SIMULATE TREATMENT OF UNCONTROLLED HEMORRHAGE
(FR) PROCÉDÉS ET KITS DE FORMATION MÉDICALE DE FAÇON À SIMULER UN TRAITEMENT EN CAS D'HÉMORRAGIE INCONTRÔLÉE
Abstract: front page image
(EN)Medical training kits and methods include a simulated liquid blood which simulates mammalian whole blood and a simulated hemostatic component. The simulated liquid blood includes a gellable component, and a simulated hemostatic component includes a gelling agent. The gelling agent causes the gellable component in the simulated liquid blood to form a mass of semi-solid or solid material in response the simulated blood being brought into contact therewith to thereby simulate blood clotting. In certain embodiments, the gellable component is chitosan and/or an alginate compound and the gelling agent is at least one compound which causes the gellable component to desolubulize, polymerize, complex, precipitate, cross-link and the like so as to form a semi-solid or solid mass of chitosan in response to physical contact between the simulated blood and the simulated hemostatic agent.
(FR)Procédés et kits de formation médicale comprenant un liquide de sang simulé qui simule du sang complet de mammifère et un composant hémostatique simulé. Le liquide de sang simulé comprend un composant gélifiable, et le composant hémostatique simulé contient un agent gélifiant. L'agent gélifiant amène le composant gélifiable dans le liquide de sang simulé à former une masse de matière solide ou semi-solide en réponse au sang simulé mis en contact avec celui-ci afin de simuler de ce fait la coagulation sanguine. Dans certains modes de réalisation, le composant susceptible de gélifier est le chitosane et/ou un composé à base d'alginate et l'agent gélifiant est au moins un composé qui amène le composant gélifiable à ne pas se dissoudre, à polymériser, être complexe, précipité, à réticuler et autre, de manière à former une masse semi-solide ou solide de chitosane en réponse à un contact physique entre le sang simulé et l'agent hémostatique simulé.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)